The DOI matches its Crossref record; 291 of the 294 references it cites were found in a registry or an index.
The Role of Natural Products in the Discovery of New Drug Candidates for the Treatment of Neurodegenerative Disorders II: Alzheimers Disease
Abstract
The present review is part II in a series (part I focuses on Parkinson's Disease) that addresses the value of natural product chemistry in the discovery of medicines for the treatment of neurodegenerative disorders. Data reviewed document that a host of products from plant species and derivatives have neuroprotectant effects in vitro and in vivo. In addition, besides neuroprotection, natural products also demonstrate biological effects that target biochemical pathways underlying associated symptoms of neurdegnerative disorders that include cognitive impairments, energy/fatigue, mood, and anxiety. This part of the review series focuses specifically upon Alzheimer's Disease (AD). AD is postulated to result from extracellular formation of amyloid plaques and intracellular deposits of neurofibrilary tangles in the hippocampus, cerebral cortex and other areas of the brain essential for cognitive function. Plaques are formed mostly from the deposition β-amyloid (Aβ), a peptide derived from the amyloid precursor protein (APP). Filamentous tangles are formed from paired helical filaments composed of neurofilament and hyperphosphorilated tau protein, a microtubule-associated protein. In addition, environmental factors can engender the production of cytokines that are closely related to the installation of an inflammatory process that contributes to neuronal death and the development and the progression of AD. In this review we focus on the recent main contribuitions of natural products chemistry to the discovery of new chemical entities usefull to the control and prevention of AD installation and progression. More than sixteen plant species, including Ginseng, Celastrus paniculatus, Centella asiatica, Curcuma longa, Ginkgo biloba, Huperzia serrata, Lycoris radiate, Galanthus nivalis, Magnolia officinalis, Polygala tenuifolia, Salvia lavandulaefolia, Salvia miltiorrhiza, Coptis chinensis, Crocus sativus, Evodia rutaecarpa, Sanguisorba officinalis, Veratrum grandiflorum and Picrorhiza kurvoa, are discussed as potential sources of active extracts. In addition, more than sixty secondary metabolites are under evaluation for their efficacy on controlling symptoms and to impede the development and progression of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vitro research studies utilizing madasiatic acid, madecassoside, asiatic acid, and asiaticosides C. asiatica derivatives have elucidated that these compounds have the ability to block hydrogen peroxide and beta-amyloid-induced cellular death, as well as to reduce the concentration of free radicals, thereby proposing a possible role for C. asiatica in AD treatment and prevention [64,132,133].”
From The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment (2022) · cites this paper as [133]
Citations
Cites
1 retracted
Thiruchelvam, M., Prokopenko, O., Cory-Slechta, D., Richfield, E., Buckley, B., & Mirochnitchenko, O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500417200 · Cited by 84
RetractedNatural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,676
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
Dorsey, E. R., Constantinescu, R., Thompson, J. P., Biglan, K., Holloway, R. G., Kieburtz, K. D., Marshall, F. J., Ravina, B. M., Schifitto, G., Siderowf, A. D., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000247740.47667.03 · Cited by 2,479
Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium Glutamate
Olney, J. (1969) · Science · doi:10.1126/science.164.3880.719 · Cited by 1,885
Medicinal natural products: A biosynthetic approach
(2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01302-2 · Cited by 1,698
Cited by
Sorted by citations
Medicinal plants in Brazil: Pharmacological studies, drug discovery, challenges and perspectives
Dutra, R. C., Campos, M. M., Santos, A. R. S., & Calixto, J. Β. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.021 · Cited by 485
Potential Impact of the Multi-Target Drug Approach in the Treatment of Some Complex Diseases
Makhoba, X. H., Viegas, C., Mosa, R. A., Viegas, F. P. D., & Pooe, O. J. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s257494 · Cited by 337
Self-citationNeuroprotective Herbs for the Management of Alzheimer’s Disease
Gregory, J., Vengalasetti, Y. V., Bredesen, D. E., & Rao, R. V. (2021) · Biomolecules · doi:10.3390/biom11040543 · Cited by 264
Dey, A., Bhattacharya, R., Mukherjee, A., & Pandey, D. K. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.12.005 · Cited by 232
Parkinson’s Disease: A Review from Pathophysiology to Treatment
Marino, B. L. B., de Souza, L. R., Sousa, K. P. A., Ferreira, J. V., Padilha, E. C., da Silva, C. H. T. D. P., Taft, C. A., & Hage-Melim, L. I. D. S. (2019) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557519666191104110908 · Cited by 239
Ayurvedic medicinal plants for Alzheimer’s disease: A review
Rao, R. V., Descamps, O., John, V., & Bredesen, D. E. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt125 · Cited by 213
Ma, H., Johnson, S. L., Liu, W., DaSilva, N. A., Meschwitz, S. M., Dain, J. A., & Seeram, N. P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020461 · Cited by 186
Dias, K. S. T., & Viegas, C. (2014) · Current Neuropharmacology · doi:10.2174/1570159x1203140511153200 · Cited by 178
Self-citationAhmad, R. S., Hussain, M. B., Sultan, M. T., Arshad, M. S., Waheed, M., Shariati, M. A., Plygun, S., & Hashempur, M. H. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/7656919 · Cited by 166
Coumarins as cholinesterase inhibitors: A review
de Souza, L. G., Rennó, M. N., & Figueroa‐Villar, J. D. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.05.001 · Cited by 162
Olatunji, O. J., Feng, Y., Olatunji, O. O., Tang, J., Ouyang, Z., & Su, Z. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.03.009 · Cited by 114
Natural Products As A Rich Source Of Tau-Targeting Drugs For Alzheimer’s Disease
Calcul, L., Zhang, B., Jinwal, U. K., Dickey, C. A., & Baker, B. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.124 · Cited by 108
Jung, H. A., Ali, M. Y., Choi, R. J., Jeong, H. O., Chung, H. Y., & Choi, J. S. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.01.014 · Cited by 99
Aalinkeel, R., Kutscher, H. L., Singh, A. K., Cwiklinski, K., Khechen, N., Schwartz, S. A., Prasad, P. N., & Mahajan, S. D. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1354002 · Cited by 99
Sadeghnia, H. R., Kamkar, M., Assadpour, E., Boroushaki, M. T., & Ghorbani, A. (2013) · Europe PMC (PubMed Central) · Cited by 96
Dong, H., Li, R., Yu, C., Xu, T., Zhang, X., & Dong, M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.11.008 · Cited by 92
Chen, Y., Zhang, D.-Q., Liao, Z., Wang, B., Gong, S., Wang, C., Zhang, M.-Z., Wang, G., Cai, H., Liao, F., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/1750-1326-10-4 · Cited by 93
The Role of Bioactive Compounds on the Promotion of Neurite Outgrowth
More, S. V., Koppula, S., Kim, I., Kumar, H., Kim, B.-W., & Choi, D. (2012) · Molecules · doi:10.3390/molecules17066728 · Cited by 89
Therapeutic Potential of Phytoconstituents in Management of Alzheimer’s Disease
Singh, S. P., Nand, S., Maurya, A., Mishra, G., Awasthi, R., Shakya, A., Chellappan, D. K., Dua, K., Vamanu, E., Chaudhary, S. K., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5578574 · Cited by 77
Lukiw, W. J. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.672559 · Cited by 76
Azizi, G., & Mirshafiey, A. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2012.705292 · Cited by 75
Cordeiro, L. M., Machado, M. L., da Silva, A. F., Baptista, F. B. O., da Silveira, T. L., Soares, F. A. A., & Arantes, L. P. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111323 · Cited by 72
Zhang, S., Shao, S.-Y., Song, X., Xia, C., Yang, Y., Zhang, P., & Chen, N. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2015.09.009 · Cited by 69
Zhang, G.-F., Zhang, Y., & Zhao, G. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.07.011 · Cited by 67
Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer’s Disease Immunotherapy
Liu, J., Yang, B., Ke, J., Li, W., & Suen, W.-C. (2016) · Drugs & Aging · doi:10.1007/s40266-016-0406-x · Cited by 67
Priglinger, E., Urmann, C., Steffenhagen, C., Bieler, L., Brunner, D., Furtner, T., Humpel, C., Bäumer, B. E., Bandtlow, C. E., Couillard‐Després, S., et al. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.06.005 · Cited by 65
Zhou, J., Qu, X., Li, Z., Wei-Ji, Liu, Q., Ma, Y., & He, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101668 · Cited by 62
Docking Studies for Multi-Target Drugs
Scotti, L., Mendonça, F. J. B., Ishiki, H. M., Ribeiro, F. F., Singla, R. K., Barbosa‐Filho, J. M., da Silva, M. S., & Scotti, L. (2015) · Current Drug Targets · doi:10.2174/1389450116666150825111818 · Cited by 58
Pharmacological exploration of traditional plants for the treatment of neurodegenerative disorders
Wahid, M., Ali, A., Saqib, F., Aleem, A., Bibi, S., Afzal, K., Ali, A., Baig, A., Khan, S. A., & Asad, M. H. H. B. (2020) · Phytotherapy Research · doi:10.1002/ptr.6742 · Cited by 61
α-Mangostin Inhibits α-Synuclein-Induced Microglial Neuroinflammation and Neurotoxicity
Hu, Z., Wang, W., Jing, L., & Jiang, C. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0264-9 · Cited by 51
Herbal Medicines for Parkinson's Disease: A Systematic Review of Randomized Controlled Trials
Kim, T., Cho, K., Jung, W., & Lee, M. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035695 · Cited by 50
Chakrabortee, S., Liu, Y., Zhang, L., Matthews, H. R., Zhang, H., Pan, N., Cheng, C., Guan, S., Guo, D., Huang, Z., et al. (2011) · Biochemical Journal · doi:10.1042/bj20111661 · Cited by 48
Sechi, S., Chiavolelli, F., Spissu, N., Cerbo, A. D., Canello, S., Guidetti, G., Fiore, F., & Cocco, R. (2015) · Journal of Veterinary Medicine · doi:10.1155/2015/412501 · Cited by 45
Ghobeh, M., Ahmadian, S., Meratan, A. A., Ebrahim‐Habibi, A., Ghasemi, A., Shafizadeh, M., & Nemat‐Gorgani, M. (2014) · Biopolymers · doi:10.1002/bip.22572 · Cited by 49
Arora, N., Shah, K., & Rai, S. P. (2015) · PROTOPLASMA · doi:10.1007/s00709-015-0829-y · Cited by 46
Arel-Dubeau, A.-M., Longpré, F., Bournival, J., Tremblay, C., Demers-Lamarche, J., Hašková, P., Attard, E., Germain, M., & Martinoli, M. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/425496 · Cited by 43
Asiaticoside, a component of Centella asiatica, inhibits melanogenesis in B16F10 mouse melanoma
Kwon, K. J., Bae, S., Kim, K., An, I. S., Ahn, K. J., An, S., & Cha, H. J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2159 · Cited by 43
A review on α-mangostin as a potential multi-target-directed ligand for Alzheimer's disease
Yang, A., Liu, C., Wu, J., Kou, X., & Shen, R. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173950 · Cited by 41
Therapeutic Potential of Different Natural Products for the Treatment of Alzheimer’s Disease
Chakraborty, B., Mukerjee, N., Maitra, S., Zehravi, M., Mukherjee, D., Ghosh, A., Massoud, E. E. S., & Rahman, M. H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6873874 · Cited by 42
Weng, J., Yen, M., & Lin, W. (2013) · Phytochemistry · doi:10.1016/j.phytochem.2013.05.022 · Cited by 38
Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases
Franco, G. D. R. R., Smid, S. D., & Viegas, C. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200720172624 · Cited by 37
Self-citationLkhagvasuren, K., & Kim, J. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.04.028 · Cited by 36
The Rational Discovery of a Tau Aggregation Inhibitor
Baggett, D. W., & Nath, A. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00581 · Cited by 34
Javed, M. N., Dahiya, E. S., Ibrahim, A. M., Alam, M. S., Khan, F. A., & Pottoo, F. H. (2020) · Springer eBooks · doi:10.1007/978-981-15-4909-0_9 · Cited by 30
The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment
Zieneldien, T., Kim, J., & Cao, C. (2022) · Geriatrics · doi:10.3390/geriatrics7020024 · Cited by 29
“asiatica in AD treatment and prevention [64,132,133].”
Chae, U., Min, J., Leem, H. H., Lee, H., Lee, H. J., Lee, S., & Lee, D. (2017) · Pharmacology · doi:10.1159/000477814 · Cited by 27
Baradaran, S., Moghaddam, A. H., & Ghasemi‐Kasman, M. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.07.001 · Cited by 30
He, J., Liang, J., Wang, L., & Hua, X.-D. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.175053 · Cited by 27
Wang, Q., Dong, X., Zhang, R., & Zhao, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210735 · Cited by 26
Herbs to curb cyclic nucleotide phosphodiesterase and their potential role in Alzheimer’s disease
Kumar, A., Sharma, V., Singh, V. P., Kaundal, M., Gupta, M., Bariwal, J. B., & Deshmukh, R. R. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.05.009 · Cited by 29
Neurotropic and neuroprotective activities of the earthworm peptide Lumbricusin
Kim, D. H., Lee, I. H., Nam, S. T., Hong, J., Zhang, P., Hwang, J. S., Seok, H., Choi, H., Lee, D. G., Kim, J. I., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.105 · Cited by 25
Porres-Martínez, M., González‐Burgos, E., Accame, M. E. C., & Gómez-Serranillos, M. P. (2013) · Food Research International · doi:10.1016/j.foodres.2013.07.029 · Cited by 24
In silico development of new acetylcholinesterase inhibitors
Pascoini, A. L., Federico, L. B., Arêas, A. L. F., Verde, B., de Freitas, P. G., & Camps, I. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1447513 · Cited by 24
Panwar, S., Uniyal, P., Kukreti, N., Hashmi, A., Verma, S., Arya, A., & Joshi, G. (2024) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14515 · Cited by 24
Talebi, M., Khoramjouy, M., Feizi, A., Ali, Z., Khan, I. A., Ayatollahi, N. A., Ayatollahi, S. A., & Faizi, M. (2023) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2023.100263 · Cited by 23
Sachdeva, P., Narayanan, K. B., Sinha, J. K., Gupta, S. K., Ghosh, S., Singh, D. K. K., Bhaskar, R., Almutary, A. G., Zothantluanga, J. H., Kotta, K. K., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231181 · Cited by 22
Firdaus, Z., & Singh, T. D. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200730155928 · Cited by 23
Save, S. N., & Choudhary, S. (2017) · RSC Advances · doi:10.1039/c6ra28440j · Cited by 21
Forestalling the Epidemics of Parkinson's Disease Through Plant-Based Remedies
Banjari, I., Marček, T., Tomić, S., & Waisundara, V. Y. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00095 · Cited by 21
Baptista, F. B. O., Arantes, L. P., Machado, M. L., da Silva, A. F., Cordeiro, L. M., da Silveira, T. L., & Soares, F. A. A. (2020) · Metallomics · doi:10.1039/d0mt00074d · Cited by 21
Abed, D. A., Lee, S., Wen, X., Ali, A. R., Mangipudy, V. S., Aleksunes, L. M., & Hu, L. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116300 · Cited by 19
Viegas, F. P. D., Gontijo, V. S., Silva, M. D. F., Ortiz, C. J. C., Franco, G. D. R. R., Ernesto, J. T., Damásio, C. M., Silva, I. M. F., Campos, T. G., & Viegas, C. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210712152532 · Cited by 20
Self-citationMyelophil ameliorates brain oxidative stress in mice subjected to restraint stress
Lee, J., Kim, H.-G., Han, J., Lee, J.-S., Son, S., Ahn, Y., & Son, C. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.07.006 · Cited by 19
Lee, J. S., Kim, J. H., Han, Y. K., Yeul, J., Kim, Y. H., Li, W., & Yang, S. Y. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.09.014 · Cited by 19
Tabrizian, K., Musavi, S., Rigi, M., Hosseindadi, F., Kordi, S., Shamshirgaran, F., Bazı, A., Shahraki, J., Rezaee, R., & Hashemzaei, M. (2019) · Human & Experimental Toxicology · doi:10.1177/0960327119839160 · Cited by 20
Nam, S. T., Kim, D. H., Lee, M. B., Nam, H. J., Kang, J. K., Park, M. J., Lee, I. H., Seok, H., Lee, D. G., Hwang, J. S., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.031 · Cited by 17
., M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660188 · Cited by 17
Aldayel, T. S., El-Hak, H. N. G., Nafie, M. S., Saad, R., Abdelrazek, H. M. A., & Kilany, O. E. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04279-z · Cited by 16
Docking of Natural Products against Neurodegenerative Diseases: General Concepts
Ribeiro, F. F., Mendonça, F. J. B., Ghasemi, J. B., Ishiki, H. M., Scotti, L., & Scotti, L. (2018) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207321666180313130314 · Cited by 16
Hannan, M. A., Haque, M. N., Munni, Y. A., Oktaviani, D. F., Timalsina, B., Dash, R., Afrin, T., & Moon, I. S. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104957 · Cited by 15
Morissette, M., Litim, N., & Paolo, T. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809593-5.00002-1 · Cited by 15
Zhou, T., Zhuang, J., Wang, Z., Zhou, Y., Li, W., Wang, Z., & Zhu, Z. (2019) · Neuroreport · doi:10.1097/wnr.0000000000001202 · Cited by 14
Cutaneous mucinosis associated with thyroid dysfunction.
Schaeffer, D., Bruce, S., & Rosén, T. (1983) · PubMed · Cited by 14
Verma, H., Kaur, S., Kaur, S., Gangwar, P., Dhiman, M., & Mantha, A. K. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04053-3 · Cited by 11
Nine Steps to Discover New Medicines from Traditional Sources: The Example of Persian Medicine
Mozaffarpur, S. A., Naseri, M., Kamalinejad, M., Shams, M. A., Memariani, Z., Moeini, R., Gorji, N., Farahani, A. M., & Shirafkan, H. (2020) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2019.0377 · Cited by 11
Yang, F., Zhou, L., Song, J., WangJinMei, A., Yang, Y., Tang, Z.-W., & Huang, Q. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00243 · Cited by 11
Pirolla, N. F. F., Batista, V. S., Viegas, F. P. D., Gontijo, V. S., McCarthy, C. R., Viegas, C., & Nascimento-Júnior, N. M. (2020) · Current Drug Targets · doi:10.2174/1389450121999200819144544 · Cited by 11
Self-citationEffect of Lycoris chejuensis and Its Active Components on Experimental Models of Alzheimer’s Disease
Kim, J., Park, Y., Chun, Y. S., Cha, J. W., Kwon, H. C., Oh, M. S., Chung, S., & Yang, H. O. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b00889 · Cited by 11
Dehydroabietylamine derivatives as multifunctional agents for the treatment of Alzheimer's disease
Cao, Y., Wang, L., Lin, Z., Liang, F., Pei, Z., Xu, J., & Gu, Q. (2014) · MedChemComm · doi:10.1039/c4md00305e · Cited by 10
Pharmacognostical Sources of Popular Medicine To Treat Alzheimer’s Disease
Kalász, H., Ojha, S. K., Tekes, K., Szőke, É., Rajesh, M., Fahim, M. F. M., Adeghate, E. A., & Adem, A. (2018) · The Open Medicinal Chemistry Journal · doi:10.2174/1874104501812010023 · Cited by 10
Chun, Y. S., Zhang, L., Li, H., Park, Y., Chung, S., & Yang, H. O. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1023-y · Cited by 10
Ortiz, C. J. C., Silva, M. D. F., Gontijo, V. S., Viegas, F. P. D., Dias, K. S. T., & Viegas, C. (2018) · Methods in pharmacology and toxicology · doi:10.1007/7653_2018_2 · Cited by 10
Self-citationGoyal, S., Arora, J., & Ramawat, K. G. (2014) · Sustainable development and biodiversity · doi:10.1007/978-3-319-09381-9_11 · Cited by 9
Centella asiatica (Gotu kola) leaves
Thakurdesai, P. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820593-8.00021-5 · Cited by 8
Franco, G. R. R., & Viegas, C. (2017) · Revista Virtual de Química · doi:10.21577/1984-6835.20170103 · Cited by 7
Self-citationNanotechnology Based Delivery Systems of Drugs Currently Used to Treat Alzheimer’s Disease
Choubdar, N., & Avizheh, S. (2019) · Nanoscience & Nanotechnology-Asia · doi:10.2174/2210681209666190228143636 · Cited by 7
Hegde, M. (2014) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.129168 · Cited by 6
“[3] However, the principle bioactive compound (s) in these plant products and/or molecular mechanisms behind their curative/preventive effects are very poorly understood, which is a roadblock to convince the more educated urban population about their benefits and to exploit these for the discovery…”
Neuropharmacological and Cognitive Effects of Celastrus paniculatus – A Comprehensive Review
Bhagya, V. R., & Jaideep, S. (2020) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2020.v65i01.013 · Cited by 6
Enogieru, A. B., & Inegbedion, G. O. (2022) · The Journal of Phytopharmacology · doi:10.31254/phyto.2022.11212 · Cited by 6
Maurya, H., Arya, R. K. K., Belwal, T., Rana, M. D., & Kumar, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819212-2.00036-0 · Cited by 6
Proposed remedies for some developmental disorders
Ibrahim, K. S., & El-Sayed, E. M. (2012) · Toxicology and Industrial Health · doi:10.1177/0748233711433937 · Cited by 6
Dey, A., Nanda, B., Nandy, S., Mukherjee, A., & Pandey, D. K. (2020) · Studies in natural products chemistry · doi:10.1016/b978-0-12-819483-6.00002-3 · Cited by 6
Khodadadi, H., Jahromi, G. P., Zaeinalifard, G., Fasihi‐Ramandi, M., Esmaeili, M. A., & Shahriary, A. (2020) · Neurophysiology · doi:10.1007/s11062-020-09861-6 · Cited by 6
Innate antiviral immunity of human PBLs and immunoregulatory activity of EGb 761
Sochocka, M., Taboł, A., Sobczyński, M., Zaczyńska, E., Czarny, A., & Leszek, J. (2013) · Open Life Sciences · doi:10.2478/s11535-013-0278-6 · Cited by 6
Lemieszewska, M., Polanowski, A., Wilusz, T., Sokołowska, A., Zambrowicz, A., Mikołajewicz, K., Macała, J., Rymaszewska, J., & Zabłocka, A. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3760124 · Cited by 6
Quinazoline-2,4(1H,3H)-dione modulates STAT3 and FOXO3a signaling in HepG2 cells
Manoharan, S., Murugesan, K., Gunasekaran, S., Vedagiri, H., & Perumal, E. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108304 · Cited by 6
Indian Traditional Herbs and Alzheimer’s Disease: Integrating Ethnobotany and Phytotherapy
Malik, J., & Choudhary, S. (2021) · Springer eBooks · doi:10.1007/978-981-15-8127-4_50 · Cited by 5
CADD Studies Applied to Secondary Metabolites in the Anticancer Drug Research
Scotti, L., Yarla, N. S., Mendonça, F. J. B., Barbosa‐Filho, J. M., da Silva, M. S., Tavares, J. F., & Scotti, L. (2018) · Springer eBooks · doi:10.1007/978-981-10-8417-1_9 · Cited by 5
Potential Treatment Strategies of Dementia With Ayurvedic Medicines
Farooqui, A. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816347-4.00009-x · Cited by 4
Ozor, I. I., Agwag, Z. N., Finbarrs-Bello, E., Ozioko, O. M., Ozioko, U. S., & Iruka, N. C. (2020) · International Journal of Neurologic Physical Therapy · doi:10.11648/j.ijnpt.20200602.12 · Cited by 4
Metadata
- Authors
- Divino da Rocha, M., Pereira Dias Viegas, F., Cristina Campos, H., Carolina Nicastro, P., Calve Fossaluzza, P., Alberto Manssour Fraga, C., J. Barreiro, E., & Viegas, C.
- Venue
- CNS & Neurological Disorders - Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2011-03-01
- Volume
- 10
- Issue
- 2
- Pages
- 251-270
- ISSN
- 1568-007X (ISSN-L)
- 1871-5273
- OpenAlex
- W2146833115
- Cited by
- 126
- References
- 294
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 7 · 2022: 5 · 2021: 11 · 2020: 18 · 2019: 7 · 2018: 13 · 2017: 6 · 2016: 9 · 2015: 8 · 2014: 12 · 2013: 8 · 2012: 10
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CNS & Neurological Disorders - Drug Targets (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, natural products, phytochemicals, neuroprotection, amyloid plaques, amyloid-beta, tau protein, neurofibrillary tangles, neuroinflammation, secondary metabolites, drug discovery, ginseng, Salvia miltiorrhiza, turmeric, Ginkgo biloba, Huperzia serrata, Centella asiatica, Celastrus paniculatus, Magnolia officinalis, Polygala tenuifolia, Picrorhiza kurroa, cognitive impairment, mood and anxiety
- MeSH terms
- Alzheimer Disease, Biological Products, Central Nervous System, Humans, Neuroprotective Agents, Neurodegenerative Diseases, Drug Discovery, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review